一、利润分配预案内容 （一）利润分配方案的具体内容 证券代码：603363 证券简称：*ST 傲农 公告编号：2025-056 福建傲农生物科技集团股份有限公司 关于 2024 年度拟不进行利润分配的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 二、2024 年度不进行利润分配的原因 经容诚会计师事务所（特殊普通合伙）审计，公司 2024 年度合并报表实现 归属于上市公司股东的净利润 579,345,018.87 元，实现归属于上市公司股东的扣 除非经常性损益的净利润-1,202,508,098.93 元；截至 2024 年 12 月 31 日，母公司 未分配利润为-2,438,933,456.60 元，公司未分配利润为-5,044,528,944.92 元；由 福建傲农生物科技集团股份有限公司（以下简称"公司"）2024 年度拟 不进行利润分配，亦不进行资本公积金转增股本。 本次利润分配预案已经公司第四届董事会第十四次会议和第四届监事会 第九次会议审议通过，尚需提交公司 2024 年年度股东大会审议。 ...

证券代码：603363 证券简称：*ST 傲农 公告编号：2025-060 福建傲农生物科技集团股份有限公司 关于申请撤销公司股票退市风险警示及其他风险警 示的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 福建傲农生物科技集团股份有限公司（以下简称"公司"）按照《上 海证券交易所上市规则》的相关规定自查，公司股票触及被实施退市风险警 示及其他风险警示的情形已消除，满足《上海证券交易所股票上市规则》9.3.7 条和第 9.8.7 条规定的可以申请撤销对公司股票实施退市风险警示及其他风 险警示的条件。公司按照相关规定向上海证券交易所申请撤销退市风险警示 及其他风险警示。 上海证券交易所自收到公司申请之后 15 个交易日内，根据实际情况， 决定是否撤销对公司股票实施的退市风险警示及其他风险警示。最终申请撤 销情况以上海证券交易所审核意见为准，届时公司将及时履行信息披露义务。 在上海证券交易所审核期间，公司股票不停牌，仍正常交易。 一、公司股票被实施退市风险警示及其他风险警示的基本情况 因公司2023年年度经审 ...

中国·北京 | | | | 序号 | 内 容 | 页码 | | --- | --- | --- | | 1 | 营业收入扣除情况的专项审核报告 | 1-2 | | 2 | 营业收入扣除情况表 | 1 | 2024 年度营业收入扣除情况的 专项审核报告 福建傲农生物科技集团股份有限公司 容诚专字[2025]361Z0351 号 容诚会计师事务所(特殊普通合伙) 关于福建傲农生物科技集团股份有限公司 容诚会计师事务所（特殊普通合伙） 总所：北京市西城区阜成门外大街 22 号 1 幢 10 层 1001-1 至 1001-26 (100037) TEL:010-6600 1391 FAX:010-6600 1392 E-mail:bj@rsmchina.com.cn https://www.rsm.global/china/ 2024 年度营业收入扣除情况的专项审核报告 容诚专字[2025]361Z0351 号 福建傲农生物科技集团股份有限公司全体股东： 我们接受委托，按照中国注册会计师审计准则审计了福建傲农生物科技集团 股份有限公司（以下简称傲农生物公司）2024 年度财务报表，并于 2025 年 4 月 28 ...

非经营性资金占用及其他关联资金 往来情况专项说明 福建傲农生物科技集团股份有限公司 容诚专字[2025]361Z0326 号 容诚会计师事务所(特殊普通合伙) 中国·北京 关于福建傲农生物科技集团股份有限公司 容诚会计师事务所（特殊普通合伙） 总所：北京市西城区阜成门外大街 号 幢 层 至 非经营性资金占用及其他关联资金往来情况专项说明 容诚专字[2025]361Z0326 号 福建傲农生物科技集团股份有限公司全体股东： 我们接受委托，依据中国注册会计师审计准则审计了福建傲农生物科技集团 股份有限公司（以下简称傲农生物公司）2024 年 12 月 31 日的合并及母公司资产 负债表，2024 年度的合并及母公司利润表、合并及母公司现金流量表和合并及母 公司所有者权益变动表以及财务报表附注，并于 2025 年 4 月 28 日出具了容诚审 字[2025]361Z0292 号的无保留意见审计报告。 根据中国证券监督管理委员会《上市公司监管指引第 8 号——上市公司资金 往来、对外担保的监管要求》的要求及上海证券交易所《上海证券交易所上市公司 自律监管指南第 2 号——业务办理》的规定，傲农生物公司管理层编制了后附 ...

福建傲农生物科技集团股份有限公司 容诚审字[2025]361Z0292 号 中国·北京 审计报告 容诚会计师事务所(特殊普通合伙) 目 录 | 序号 | 内 | 容 | 页码 | | --- | --- | --- | --- | | 1 | 审计报告 | | 1-6 | | 2 | 合并资产负债表 | | 1 | | 3 | 合并利润表 | | 2 | | 4 | 合并现金流量表 | | 3 | | 5 | 合并所有者权益变动表 | | 4 | | 6 | 母公司资产负债表 | | 5 | | 7 | 母公司利润表 | | 6 | | 8 | 母公司现金流量表 | | 7 | | 9 | 母公司所有者权益变动表 | | 8 | | 10 | 财务报表附注 | | 9-228 | 审 计 报 告 容诚会计师事务所（特殊普通合伙） 总所：北京市西城区阜成门外大街 号 幢 层 - 至 - - - - 容诚审字[2025]361Z0292 号 福建傲农生物科技集团股份有限公司全体股东： 一、审计意见 我们审计了福建傲农生物科技集团股份有限公司（以下简称傲农生物公司） 财务报表，包括 2024 年 12 月 31 日 ...

2023 年度审计报告 非标意见涉及事项影响已消除的审核报告 福建傲农生物科技集团股份有限公司 容诚专字[2025]361Z0350 号 容诚会计师事务所(特殊普通合伙) 中国·北京 目 录 序号 内 容 页码 | 1 | 2023 | 年度审计报告非标意见涉及事项影响已消除 | 1-2 | | --- | --- | --- | --- | | | 的审核报告 | | | | | 2023 | 年度审计报告非标意见涉及事项影响已消除 | | 的专项说明 2 容诚会计师事务所（特殊普通合伙） 总所：北京市西城区阜成门外大街 号 幢 层 至 关于福建傲农生物科技集团股份有限公司 2023 年度审计报告非标意见涉及事项影响已消除的审核报告 容诚专字[2025]361Z0350 号 福建傲农生物科技集团股份有限公司全体股东： 我们接受委托，审核了后附的福建傲农生物科技集团股份有限公司（以下简称 傲农生物公司）董事会编制的《关于福建傲农生物科技集团股份有限公司 2023 年 度审计报告非标意见涉及事项影响已消除的专项说明》（以下简称《非标意见涉及 事项影响已消除的专项说明》）。 一、对报告使用者和使用目的的限定 本审 ...

RSM 容诚 内部控制审计报告 容诚会计师事务所 (特殊普通合伙) 中国 · 北京 ： HTHE 内部控制审计报告 容诚审字[2025]361Z0408 号 福建傲农生物科技集团股份有限公司 容诚审字[2025]361Z0408 号 福建傲农生物科技集团股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我 们审计了福建傲农生物科技集团股份有限公司（以下简称"傲农生物公司"）2024 年 12 月 31 日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部 控制评价指引》的规定,建立健全和有效实施内部控制,并评价其有效性是傲农 生物公司董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表 审计意见，并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性,存在不能防止和发现错报的可能性。此外,由于 情况的变化可能导致内部控制变得不恰当,或对控制政策和程序遵循的程度降低, 根据内部控制审计结果推测未来内部控制的 ...

募集资金存放与实际使用情况鉴证报告 福建傲农生物科技集团股份有限公司 容诚专字[2025]361Z0325 号 容诚会计师事务所(特殊普通合伙) 中国·北京 目 录 | 序号 | 容 内 | 页码 | | --- | --- | --- | | 1 | 募集资金存放与实际使用情况鉴证报告 | 1-2 | | 2 | 募集资金存放与实际使用情况的专项报告 | 1-10 | 容诚会计师事务所（特殊普通合伙） 总所：北京市西城区阜成门外大街 号 幢 层 至 募集资金存放与实际使用情况鉴证报告 容诚专字[2025]361Z0325 号 福建傲农生物科技集团股份有限公司全体股东： 我们审核了后附的福建傲农生物科技集团股份有限公司（以下简称傲农生物 公司）董事会编制的 2024 年度《募集资金存放与实际使用情况的专项报告》。 一、 对报告使用者和使用目的的限定 四、 工作概述 我们按照《中国注册会计师其他鉴证业务准则第 3101 号－历史财务信息审计 或审阅以外的鉴证业务》的规定执行了鉴证业务。该准则要求我们计划和实施鉴证 工作，以对鉴证对象信息是否不存在重大错报获取合理保证。在鉴证过程中，我们 实施了包括检查会计记录等 ...

Financial Performance - The company achieved a net profit of RMB 63,091,581.34 for the 2024 fiscal year, with a net profit attributable to shareholders of RMB 579,345,018.87[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was negative RMB 1,202,508,098.93[6]. - As of December 31, 2024, the company's undistributed profits amounted to negative RMB 5,044,528,944.92[6]. - The company plans not to distribute profits or increase capital reserves due to negative net profit and undistributed profits[6]. - The company has received a standard unqualified audit report from Rongcheng Accounting Firm[5]. - The board of directors has approved the profit distribution plan, which will be submitted for shareholder approval[7]. - The company's operating revenue for 2024 was CNY 8,762,672,770.35, a decrease of 54.97% compared to CNY 19,457,641,131.79 in 2023[25]. - The net profit attributable to shareholders for 2024 was CNY 579,345,018.87, a significant recovery from a loss of CNY 3,650,822,227.67 in 2023[25]. - The net cash flow from operating activities for 2024 was -CNY 116,781,234.85, down 111.87% from CNY 984,006,832.75 in 2023[25]. - The total assets at the end of 2024 were CNY 9,506,097,034.21, a decrease of 30.23% from CNY 13,625,213,490.65 at the end of 2023[25]. - The basic earnings per share for 2024 was CNY 0.67, compared to -CNY 4.21 in 2023[26]. - The company reported a significant non-recurring loss of CNY 558,183,711.67 from the disposal of non-current assets in 2024[30]. - The company achieved a net profit of CNY 1,398,334,175.50 in Q4 2024, marking a strong recovery compared to losses in previous quarters[29]. Business Segments Performance - The company’s feed business generated revenue of CNY 580,780.59 million, down 45.76% year-on-year, with sales volume of 172.18 thousand tons, a decrease of 36.70%[41]. - The pig farming segment reported revenue of CNY 190,263.77 million, a decline of 64.22%, with a total of 209.84 thousand pigs slaughtered, down 64.19% year-on-year[42]. - The slaughtering and food processing segment's revenue was CNY 99,270.43 million, down 64.64%, with a total of 49.62 thousand pigs slaughtered, a decrease of 29.97%[42]. - The overall gross margin for the feed business was 5.29%, a decrease of 1.42 percentage points compared to the previous year[41]. - The gross margin for the pig farming business improved to 0.73%, an increase of 27.91 percentage points year-on-year, attributed to rising pig prices[42]. - The gross margin of the company's slaughter food segment was 8.44%, an increase of 13.36 percentage points year-on-year, primarily due to a reduction in the scale of live pig trading[43]. Strategic Initiatives and Future Plans - The company plans to focus on high-quality development and market expansion in response to the overall economic growth of 5.0% in 2024[33]. - The company aims to strengthen its supply chain and develop differentiated pork products to enhance brand competitiveness and consumer loyalty[38]. - The company plans to enhance its slaughtering and meat processing capabilities by establishing new facilities in key consumption areas like Fujian and Jiangxi[38]. - The company plans to strategically expand its slaughter and processing capacity in key breeding areas to enhance its competitive position in the industry[51]. - The company aims to achieve a 65% reduction in antibiotic use in large-scale farms by 2030, promoting resource conservation and efficient use of inputs[52]. - The company is focusing on three main business areas: feed, pig farming, and slaughter food, and will no longer engage in large-scale raw material trading[44]. - The company plans to optimize its pig farming layout, focusing on Fujian and Jiangxi provinces, to achieve full production capacity[64]. - The company aims to enhance cost competitiveness through optimized breed structure, refined production management, and improved biosecurity measures[64]. Research and Development - The company has developed a comprehensive feed product line, including pig feed, poultry feed, and aquaculture feed, with a strong competitive edge in early-stage pig feed[54]. - The company is in the final production trial phase for the development of anti-disease and growth-promoting piglet feed, aimed at enhancing the immunity of piglets[92]. - The company is in the final production trial phase for the development of functional feed to improve the intestinal health of sows[92]. - The company is in the research phase for the development of specialized feed for the flower carp intensive farming model, with the goal of creating dedicated feed for this farming method[92]. - The company has completed the trial production phase for the development of high-efficiency aquatic feed utilizing emulsifiers, targeting the creation of high-quality aquatic feed[92]. Environmental and Compliance Efforts - The company has established a comprehensive environmental protection mechanism[186]. - The company has implemented measures to reduce wastewater pollution, utilizing a self-built wastewater treatment system for irrigation purposes[199]. - The company has installed air pollution control equipment to ensure compliance with emission standards for waste gas[199]. - The company has adhered to environmental monitoring regulations, executing its self-monitoring plan without omissions throughout 2024[194]. - The company has received fines totaling RMB 737,800 and RMB 45,000 for unauthorized land use and failure to restore vegetation, respectively[196]. Governance and Management - The company maintains an independent governance structure, ensuring that all shareholders, especially minority shareholders, can exercise their voting rights fairly and equally[132]. - The company has established an independent financial department and accounting system, ensuring that it makes independent financial decisions without interference from the controlling shareholder[135]. - The company has a complete and independent personnel management system, ensuring that all senior management personnel are employed and compensated solely by the company[135]. - The company is focused on improving its internal control systems and risk management capabilities to ensure compliance and operational stability[126]. - The company has implemented a salary system that combines base salary, performance bonuses, and benefits, aiming to attract and retain core talent[169]. Employee and Talent Development - The company emphasizes talent development through standardized processes to improve employee capabilities and align personal growth with corporate vision[170]. - Training initiatives in 2024 will focus on business needs and efficient management, with a mix of online and offline training programs[171]. - The employee composition includes 2,674 production personnel, 1,026 sales personnel, 132 technical personnel, 265 financial personnel, and 1,123 administrative personnel[168]. Market and Competitive Landscape - The feed industry in China is expected to continue growing due to increasing demand for meat products, supported by rising incomes and urbanization[115]. - The company has identified a significant opportunity for further consolidation in the feed industry, which is becoming increasingly competitive[114]. - The company is focusing on expanding its market presence through mergers and acquisitions, aiming to enhance its competitive advantage in the feed industry[114]. Shareholder Relations and Financial Structure - The company plans to provide guarantees for its industry chain partners in 2024, indicating a strategic focus on collaboration[140]. - The company has approved a proposal to transfer 51% equity of a subsidiary, which may impact its financial structure and operational strategy[140]. - The company is set to hold its annual shareholder meeting on June 6, 2024, to discuss various financial and operational matters[140]. - The company has reported a total of 99,452,174 shares outstanding, with a decrease of 15,791,600 shares compared to the previous period[144].

Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,783,121,593.70, a decrease of 25.95% compared to CNY 2,407,845,116.90 in the same period last year[4] - Net profit attributable to shareholders was CNY 218,305,329.33, a significant recovery from a loss of CNY 292,019,915.86 in the previous year[4] - Basic and diluted earnings per share were both CNY 0.08, compared to a loss of CNY -0.34 per share in the previous year[5] - Operating profit for Q1 2025 was CNY 226,825,281.34, compared to a loss of CNY 375,395,437.68 in Q1 2024[20] - Net profit for Q1 2025 was CNY 221,671,023.85, recovering from a net loss of CNY 372,743,346.37 in Q1 2024[21] - The company reported a significant investment income of CNY 250,414,865.92 in Q1 2025, compared to a loss of CNY 2,766,470.08 in Q1 2024[20] Cash Flow - The net cash flow from operating activities was negative at CNY -345,853,887.69, worsening from CNY -28,696,382.95 in the same period last year[4] - Total cash inflow from operating activities was 1,691,355,405.04, compared to 2,325,261,513.89 previously[24] - Cash outflow from operating activities totaled 2,037,209,292.73, down from 2,353,957,896.84[24] - The net cash flow from investing activities was -92,430,532.43, a significant decline from 60,620,390.18 in the prior period[24] - The net cash flow from financing activities was -156,877,037.09, worsening from -39,797,304.02 in the previous period[24] - The ending cash and cash equivalents balance was 536,523,685.07, down from 1,131,687,533.40 at the beginning of the period[24] Assets and Liabilities - Total assets decreased by 3.29% to CNY 9,193,538,073.43 from CNY 9,506,097,034.21 at the end of the previous year[5] - The company's current assets decreased to RMB 3,268,062,678.55 from RMB 3,699,211,726.04, reflecting a decline of about 11.63%[15] - The company's total liabilities decreased to CNY 5,769,579,246.89 in Q1 2025 from CNY 6,444,948,812.96 in Q1 2024[17] - Total liabilities decreased to RMB 5,705,240,309.62 from RMB 6,178,313,232.07, indicating a decline of approximately 7.65%[16] - The company reported a total equity of RMB 3,488,297,763.81 as of March 31, 2025, down from RMB 3,327,783,802.14, reflecting an increase of about 4.83%[16] - Total equity increased to CNY 3,423,958,826.54 in Q1 2025 from CNY 3,061,148,221.25 in Q1 2024[17] Operational Insights - The decline in operating revenue was mainly due to reduced feed sales and a decrease in the number of pigs sold[7] - The company plans to focus on improving operational efficiency and exploring new market opportunities in the upcoming quarters[7] - The company has a total of 540,000 pigs, including 109,200 breeding sows as of the end of the reporting period[12] Inventory and Borrowings - The company's inventory increased to RMB 834,543,287.70 from RMB 816,935,693.48, showing a growth of approximately 2.07%[15] - The company's short-term borrowings decreased to RMB 555,693,967.33 from RMB 765,327,341.90, a reduction of about 27.39%[16] - The company’s long-term borrowings increased to RMB 1,512,720,086.14 from RMB 1,462,234,553.47, an increase of approximately 3.93%[16] Accounting Standards - The company will not apply new accounting standards starting from 2025[25]